18:36 , Jan 25, 2019 |  BC Week In Review  |  Company News

B-MoGen, CytoSen to develop NK cell therapies

B-MoGen Biotechnologies Inc. (Minneapolis, Minn.) and CytoSen Therapeutics Inc. (Orlando, Fla.) partnered to develop gene-modified NK cell therapies. B-MoGen will use its non-viral gene delivery platform with CytoSen's nanoparticle expansion platform to improve efficacy and...